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CC BY-NC-ND license (http://creativAbstract Background: Loss of intestinal integrity is a critical contributor to excessive inflam-
mation following severe trauma or major surgery. In the case of enterocyte damage, intestinal
fatty acid-binding protein (IFABP) is released into the extracellular space. Excessive produc-
tion of interleukin (IL)-6 can induce systemic inflammatory response syndrome (SIRS). Howev-
er, the correlation of IL-6 with gut barrier failure and bacterial translocation in critically ill
patients has not been well characterized.
Purposes: To define the relationship between enteric bacterial loads and IL-6 levels in patients
with SIRS.
Methods: Variables related to prognosis and treatment were measured in 85 patients with SIRS
upon admission to the emergency room. IL-6 and IFABP were measured using an enzyme-linked
immunosorbent assay. Enteric bacterial loads in blood were measured through quantitative
real-time polymerase chain reaction with primers specific for enteric bacteria.
Results: Multivariate analysis revealed a positive correlation between enteric bacterial loads
and IL-6 levels in blood. Elevated IFABP concentration was associated with low blood pressure,
high respiration rate, hyperglycemia, and high Sequential Organ Failure Assessment score.
Elevated C-reactive protein concentrations were associated with higher soluble CD14 levels
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Enteric bacterial loads correlate with IL-6 levels 209Conclusion: Enterocyte damage is associated with hypotension and tachypnia in patients with
SIRS. Gut function failure may permit enteric bacteria to enter the blood, thereby elevating
IL-6 levels and inducing a systemic inflammatory response, resulting in multiple organ failure.
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by-nc-nd/4.0/).1. Introduction
Excessive production of proinflammatory cytokines such as
tumor necrosis factor (TNF)-a, interleukin (IL)-1b, IL-6, and
IL-8 by immunocompetent cells can induce systemic
inflammatory response syndrome (SIRS).1 Among these
proinflammatory cytokines, IL-6 has a longer half-life than
TNF-a and IL-1b do, and blood IL-6 levels remain consistently
elevated in people with various diseases.1 IL-6 has been
implicated as being responsible for increased gut mucosal
permeability in mice with a condition associated with sys-
temic inflammation, namely, polymicrobial peritonitis
induced by cecal ligation and perforation.2 IL-6 is a pleio-
tropic cytokine involved in both proinflammatory and anti-
inflammatory responses by regulating leukocyte function
and apoptosis.3,4 It is a crucial cytokine associated with in-
flammatory bowel disease as well as other chronic inflam-
matory diseases and cancer.5 However, the correlation of IL-
6 with gut barrier failure and bacterial translocation in
critically ill patients has not been well characterized.
The intestinal tract acts as a major physical barrier
between the microflora and internal host tissue, and it
responds to the mucosal innate system through commensal
microflora.6 The mucosal barrier is composed of epithelial
apical junction complexes, consisting of tight junctions and
adherence junctions.7 Gut barrier function failure due to a
major stress insult permits bacterial and endotoxin
translocation, which triggers systemic cytokines and
exacerbates a systemic immunoinflammatory response that
results in organ failure.8 Intestinal barrier failure is a
crucial issue in the treatment of critically ill patients.
Bacterial translocation from the intestinal tract is a major
cause of thermal injury-induced sepsis and mortality.9
Providing enteral nutrients shortly after injury alters the
gut flora and protects the immunocompromised, stressed,
or thermally injured patients through an unknown
mechanism.10 However, small intestine dysfunction is
frequently underdiagnosed and associated with poor
prognosis in critically ill patients.11
Intestinal fatty acid-binding protein (IFABP), which is a
small cytoplasmic protein specifically localized in small
bowel enterocytes and involved in fatty acid transport, is
normally undetectable in plasma.12 In healthy adults, small
bowel hypoperfusion during submaximal effort was shown
to cause acute reduction of enterocyte mass.13 In the case
of enterocyte damage, IFABP is released into the extra-
cellular space, leading to increased concentrations of IFABP
in plasma and urine. Patients with septic shock show
increased urinary IFABP concentrations, suggesting that the
shock condition is associated with enterocyte damage.14
Failure of the gut mucosal barrier to exclude bacteria andendotoxins from the portal and systemic circulation is
responsible for the development of sepsis and multiple
organ failure.8 Although experimental data are compelling,
corroborative evidence from studies involving patients with
sepsis is scarce.
Intestinal failure is one the most frequent complications
among patients with sepsis. However, treatment in-
terventions aimedat improving gastrointestinal (GI) perfusion
have failed to improve outcomes.15 We hypothesize that gut
barrier function failure due toamajor stress insultmaypermit
bacterial translocation, triggering IL-6 release and resulting in
organ failure. To test this hypothesis, we examined the IFABP
levels, IL-6 levels, enteric bacterial loads, and soluble CD14
(sCD14) in the blood of patients with SIRS and defined the
relationship with variables related to prognosis and
treatment. The primary objective of this study was to
evaluate the changes in blood IL-6 levels in these patients and
the relationship of the changes with enteric bacterial loads.
The second objective was to identify the factors associated
with plasma IFABP concentrations in a population of patients
with SIRS. In the future, controlling the contributing factors of
enterocyte damage to reduce enteric bacteria translocation
in patientswith SIRS could be a useful therapeutic strategy for
preventing multiple organ failure in patients with severe
trauma or those having undergone major surgery.2. Methods2.1. Study setting and patients
This prospective study was conducted at the emergency
department of the Zuoying Armed Forces General Hospital,
Kaohsiung, Taiwan. This study was approved by the local
ethics committee (EC-No. ZAFGH 101-06) and conducted in
accordance with the guidelines of the Declaration of
Helsinki (1964), including current revisions. Patients
admitted to the emergency department were screened for
the following inclusion criteria: two or more SIRS criteria
[temperature, >38C or <36C; pulse, >90 beats/min;
respiratory rate, >20 breaths/min; or PaCO2, <32 mmHg;
WBC count, >12,000 or <4000 cells/mL or >10% immature
(band forms)], age >20 years, and able to give consent. The
exclusion criteria for participation in the study were as
follows: malignancies; surgery within 72 hours prior to
admission; infection with HIV, fungi, or parasites; or
inability to sign the consent form. The patients were
informed about the trial, and they signed a consent form to
confirm their participation. To ensure anonymity, every
participant was consecutively assigned an identification
number, which was used for further analysis.
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Variables at admission to the emergency department were
retrospectively collected. The following variables were
recorded: age, sex, systolic blood pressure (BP), diastolic
BP, mean arterial pressure, respiration rate, blood sugar,
and Sequential Organ Failure Assessment (SOFA) score upon
emergency room (ER) admission.2.3. Serum IL-6 and soluble CD14 measurement
Serum IL-6 levels were measured through an enzyme-linked
immunosorbent assay (ELISA). The human ELISA kit
(eBioscience) was used for the IL-6 assay. The blood was
centrifuged at 1000g, at 4C for 15 minutes, and the serum
was collected for use. The ELISA plates were coated with
100 mL capture antibody per well at 4C and maintained
overnight. After appropriate washing, 200 mL of assay
dilution buffer was added per well at room temperature for
blocking for 1 hour. The sample and serial dilutions of
standards were added to the plate and incubated at 4C
overnight. After a coat of detection antibody was applied,
avidineHRP was added and incubated at room temperature
for 30 minutes. The substrate 3,30,5,50-tetramethylbenzi-
dine was added and incubated for 15 minutes. Finally, 2N
H2SO4 was added to stop the reaction, and the absorbance
at 450 nm was measured using an ELISA reader.
Soluble CD14 concentrations in blood were measured
through an ELISA (R&D Systems, Minneapolis, MN) following
the manufacturer’s instructions.2.4. Bacterial DNA isolation and quantitative
real-time polymerase chain reaction
Bacterial DNA was isolated from human whole blood by
using a kit (GeneMark). Eight volumes of 1 RBC lysis
solution was added to the whole blood (200 mL) and
incubated at room temperature for 5 minutes. For the
real-time polymerase chain reaction (PCR) analysis, 2 ng of
experimental sample DNA was added to 20 mL of the
reaction mixture containing supermix and 0.2mM each of
sense and antisense primers. The primers used to amplify
the wec F gene are as follows: forward, TGCCGTAAC
TTCGGGAGAAGGCA; reverse, TCAAGGCTCAATGTTCAGT
GTC. These primers are specific for enteric bacterial
species.16 Amplification was then performed in an iCycler
Fluorescence Thermocycler (ABI). Fluorescence data were
captured during the 10-second dwell to ensure that primer
dimmers were not contributing to the fluorescence signal
generated with SYBR Green I DNA dye. The experimental
threshold cycle was compared with an Escherichia coli
bacterial DNA standard curve for quantification.2.5. IFABP measurement
IFABP is an early and sensitive marker of enterocyte injury. To
evaluate the presence and extent of enterocyte injury, serum
IFABP concentrations in blood were measured using the ELISA
test (R&D Systems) following themanufacturer’s instructions.2.6. Statistical analysis
Data are expressed as themean standard deviation,median
and interquartile ranges, and number and percentage. For
normally distributed data, continuous variables were
compared using the Student t test. Pearson’s correlation
coefficients were used to evaluate the correlations between
continuous variables. Linear regression modeling was
performed to test for the effect of the different variables on
IFABP or IL6 concentrations. Variables with p < 0.05 in the
univariable linear regression analysis were selected for a
multivariate analysis. Statistical analysis was performed using
IBM SPSS Statistics Version 18 (IBMCompany, Chicago, U.S.A.).
Statistical significance was defined at p < 0.05 (two-tailed).3. Results3.1. Baseline and parameters of participants
Between January 1, 2010 and January 1, 2011, 98 patients
were included in the study. Thirteen patients were
excluded because of missing data. Thus, 85 patients were
enrolled in the study. The main characteristics of the
studied patients are listed in Table 1. Chest disease was
diagnosed in 23 patients (27%). Among those patients, the
most common diagnosis was pneumonia. Cardiovascular
disease was diagnosed in four patients (5%). Urinary tract
infection was diagnosed in 18 patients (21%). Among these
patients, the most common diagnosis was urosepsis.
Intra-abdominal infection was observed in six patients (7%).
Burns were diagnosed in eight patients (9%). GI tract
bleeding was diagnosed in three patients (3.5%). Soft tissue
infection was diagnosed in 15 patients (18%). Eight patients
were categorized as “others” (4 with acute renal failure, 2
with pulmonary edema, and 2 with ileus). Seven patients
(8%) died in the intensive care unit (ICU). Seventy-eight
patients (92%) survived.3.2. Enteric bacteria primers in quantitative
assessment of bacterial translocation
This protocol involves primers that amplify a region ofwec F, a
gene that encodes a transferase, which is crucial for creating
the repetitive trisaccharide unit of the enterobacterial (EB)
common antigen. These EB primers amplify DNA from enteric
bacterial species, including E. coli, Klebsiella pneumoniae,
Salmonella spp.,Enerobacter spp.,Serratia spp., andShigella
spp.16 To determine whether these primers could be used to
quantitatively measure enteric bacterial loads, we serially
spiked human blood samples with increasing amounts of K.
pneumoniae. AfterDNA isolation,wecompared theamountof
enteric bacterial DNA to a known E. coli standard (Figure 1A)
through quantitative real-time PCR using the EB primers. The
load of bacterial DNA in the spiked blood correlated signifi-
cantly with the E. coli standard (Figure 1B), suggesting that
these primers can be used to quantitatively measure the
presence of enteric bacteria. We also confirmed that EB
primers amplify DNA from E. coli. and K. pneumoniae, but not
from Gram-positive organisms (data not shown).
Figure 1 EB primers are useful in the quantitative
measurement of enteric bacterial loads. (A). Real-time PCR
standard curve obtained by plotting the threshold cycle values
against an Escherichia coli log scale. (B) Human blood
was spiked with serially increasing inocula of Klebsiella
pneumoniae. Subsequently, DNAwas isolated, and real-time PCR
was performed with EB primers to compare the quantities of
amplicons with the quantity of an E. coliDNA standard.We found
a significant correlation between the E. coli standard and the
DNA isolated from the spiked blood. Ct Z cycle threshold;
EBZ enterobacterial; PCRZ polymerase chain reaction.
Table 1 Baseline characteristics of the study populations
at SER admission.
Variable n Z 85




Systolic blood pressure (mm Hg) 99 [78e119]
Diastolic blood pressure (mm Hg) 55 [46e67]
Mean blood pressure (mm Hg) 71 [55e84]
Respiration rate (breaths/min) 23 [20e29]
Heart rate (beats/min) 110 [96e119]
C-reactive protein (mg/L) 9.2 [3.7e17.1]
IL-6 (pg/ml) 120.6 [46.8e398]
sCD14 (pg/ml) 2543 [397e3797]
IFABP (pg/ml) 24.01 [4.92e135.7]
Blood sugar (mg/dl) 168 [137e268]






Chest diseases 23 [32]




GI bleeding 3 [4]
Soft tissue infection 15 [17]
Others 8 [9]
n (%); median [interquartile range].
IFABP Z intestinal fatty acid-binding protein.
APACHE II Z acute physiology and chronic health evaluation II.
SOFA Z Sequential Organ Failure Assessment.
sCD14 Z soluble CD14.
UTI Z urinary tract infection.
IAI Z intra-abdomen infection.
CV Z cardiovascular.
GI Z gastrointestinal.
Enteric bacterial loads correlate with IL-6 levels 2113.3. Enteric bacterial translocation correlated
positively with blood IL-6 levels in patients with SIRS
We evaluated the bacterial translocation of patients with
SIRS patients upon admission to the ER by measuring the
bacterial loads of enteric organisms in blood. Using a linear
regression analysis, we compared the enteric bacterial
loads with IL-6 in blood measured in the patients upon
admission to the ER. The blood IL-6 levels ranged between
100 and 1000 pg/mL in surviving patients with sepsis.17 The
average blood IL-6 levels in our patients were 120.6 pg/mL.
The results of the multivariate regression analysis demon-
strated a positive correlation between the enteric bacterial
loads and IL-6 levels (Table 2), suggesting that the elevated
IL-6 levels correlated positively with the enteric bacterial
loads in these patients.3.4. Hypotension was associated with enterocyte
injury in patients with SIRS
The results of a linear regression analysis between IFABP
concentrations and BP upon admission to the ER indicated
that the patients with low systolic pressure had significantly
elevated IFABP concentrations (r Z 0.361, p Z 0.003;
Figure 2A). Patients with low diastolic BP also had signifi-
cantly elevated IFABP concentrations (rZ 0.319, pZ 0.012;
Figure 2B). Similarly, patients with low mean BP exhibited
increased IFABP concentrations (r Z 0.359, p Z 0.003;
Figure 2C). Moreover, the plasma IFABP concentrations in
Table 2 Results of multivariate regression analysis for the
contributing factors of IL-6.
b p value r









* Z statistically significant
SBP Z systolic blood pressure.
DBP Z diastolic blood pressure.
RR Z respiration rate.
IFABP Z intestinal fatty acid-binding protein.
APACHE II Z acute physiology and chronic health evaluation II.
SOFA Z Sequential Organ Failure Assessment.
sCD14 Z soluble CD14.
NS Z not significant.
212 T.-B. Tsay et al.patients with a systolic BP of <90 mmHg were higher than
those in patients with a systolic BP of >90 mmHg (p < 0.05;
Figure 2D). These results suggest that hypotension is asso-
ciatedwith enterocyte injury, and patients with a systolic BP
of <90 mmHg show increased enterocyte damage.3.5. Tachypnea was associated with enterocyte
damage in patients with SIRS
The results of a linear regression analysis between IFABP
concentrations and the respiration rate upon admission to
the ER indicated that IFABP concentrations increased with
the respiration rate (r Z 0.3, p Z 0.021; Figure 3A).
Moreover, plasma IFABP concentrations were significantly
higher in patients with a respiration rate of >20 breaths/
min than in those with a respiration rate of <20 breaths/
min (p < 0.05; Figure 3B). These results suggest that
tachypnea is associated with enterocyte injury, and
enterocyte damage is significantly higher in patients with a
respiration rate of >20 breaths/min.Figure 2 Lower BP was associated with elevated IFABP levels
in patients with SIRS. (A). Patients with low systolic pressure
had elevated IFABP levels. (B) Patients with low diastolic BP
upon admission to the ER also had elevated IFABP levels. (C)
Patients with low mean BP exhibited elevated IFABP levels. (D)
Serum IFABP levels were higher in patients with a systolic BP of
<90 mmHg upon to the ER than in those with a systolic BP
90 mmHg. *p < 0.05. BP Z blood pressure; ER Z emergency
room; IFABP Z intestinal fatty acid-binding protein;
SIRS Z systemic inflammatory response syndrome.3.6. High blood sugar levels were associated with
enterocyte injury in patients with SIRS
The association of hyperglycemia with increased mortality
in patients with SIRS is unclear. The results of a linear
regression analysis between IFABP concentrations and blood
sugar upon admission to the ER suggested that the patients
with increased blood sugar levels had significantly elevated
IFABP concentrations (r Z 0.291, p < 0.05). We tested
several values in the linear regression analysis and found
that 230 mg/dL is the optimum cutoff value. Moreover,
plasma IFABP concentrations were significantly higher in
Figure 4 Higher SOFA scores correlated significantly with
elevated IFABP levels in the patients with SIRS (r Z 0.319,
p Z 0.007). IFABP Z intestinal fatty acid-binding protein;
SOFAZ Sequential Organ Failure Assessment; SIRS Z systemic
inflammatory response syndrome.
Figure 3 Higher respiration rate and hyperglycemia were
associated with the elevated IFABP levels in the patients with
SIRS. (A) Patients with a high respiration rate showed elevated
IFABP levels. (B) Serum IFABP levels were higher in the patients
with a respiration rate of 20 breaths/min than in those with a
respiration rate of <20 breaths/min upon admission to the ER.
(C) Plasma IFABP concentrations were higher in patients with a
blood sugar level of 230 mg/dL than in those with a blood
sugar of <230 mg/dL upon admission to the ER. *p < 0.05.
ER Z emergency room; IFABP Z intestinal fatty acid-binding
protein; SIRS Z systemic inflammatory response syndrome.
Enteric bacterial loads correlate with IL-6 levels 213patients with blood sugar levels 230 mg/dL than in those
with blood sugar levels of<230 mg/dL (p< 0.05; Figure 3C).
These results indicate that hyperglycemia is associated
with enterocyte injury, and enterocyte damage significant
increases in patients with blood sugar levels of 230 mg/dL.Figure 5 Elevated C-reactive protein concentrations were
associated with high sCD14 levels in patients with SIRS.
sCD14Z soluble CD14; SIRSZ systemic inflammatory response
syndrome.3.7. Enterocyte damage was associated with SOFA
score
To examine the relationship between enterocyte injury and
multiple organ failure, we calculated the SOFA scores upon
admission to the ER. The results of a linear regression
analysis between IFABP concentrations and SOFA scores
indicated that the IFABP concentrations increased with the
SOFA score (r Z 0.331, p Z 0.007; Figure 4). These resultssuggest that higher IFABP concentrations indicate multiple
organ failure in patients with SIRS.
3.8. Soluble CD14 was associated with C-reactive
protein
To examine the relationship between sCD14 and inflam-
mation, C-reactive protein levels were measured upon
admission to the ER. The results of a linear regression
analysis between sCD14 concentrations and C-reactive
protein levels indicated a significantly positive correlation
between them (r Z 0.476, p < 0.0001; Figure 5).
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The role of gut injury and inflammation in major trauma-
induced SIRS and multiple organ dysfunction syndrome has
been known for decades.18 Cross-talk between commensal
intestinal microflora and systemic innate immunity
remains undefined. Deitch19 discovered that the systemic
spread of gut-derived factors leading to lung injury and
systemic inflammation occurs through the intestinal
lymphatics. Bacterial fragments and toxic components,
such as lipopolysaccharides, lipoteichoic acid, endotoxin,
superantigen, and enterotoxin invasion, can induce
inflammatory cytokine secretion and trigger a systemic
inflammatory response.20 Patients with end-stage renal
disease have significantly higher IL-6 levels when bacterial
DNA is present.21 Furthermore, blood IL-6 levels are also
associated with the survival of patients with burns and
sepsis.22 Oda et al23 reported that IL-6 levels are elevated
in patients with SIRS or sepsis and extremely high in
patients with septic shock. However, blood IL-6 levels upon
admission into ER do not differ significantly between
survivors and nonsurvivors.23 Moreover, Giannoudis et al24
reported that elevated IL-6 is a reliable diagnostic
indicator of a SIRS state. A cutoff value of 200 pg/dL was
shown to be significantly diagnostic of a SIRS state.24 We
previously demonstrated that thermal injury does not
induce high IL-6 levels in mice on the 2nd day after the
injury. IL-6 levels were significantly elevated in mice
subjected to a thermal injury and then treated with
antibiotics, suggesting that bacterial translocation induced
by thermal injury followed by antibiotic treatment may
increase IL-6 levels in blood.25 High blood IL-6 levels
correlated with hyperglycemia and difficulties in glucose
control in septic patients.17 Our data further indicate that
enteric bacterial loads in blood correlate positively with IL-
6 levels in the blood of patients with SIRS. This suggests
that IL-6 levels in blood may be an indicator of enteric
bacterial translocation in these patients. In addition,
enteric bacterial translocation may induce a pulmonary or
systemic inflammatory response through IL-6 levels in
blood. In summary, our results indicate that a failure of gut
barrier function due to mesenteric ischemia permits
bacterial and endotoxin translocation, which may triggers
systemic IL-6 levels and exacerbate a systemic inflamma-
tory response that results in organ failure.
SIRS is defined as an acute host reaction to various
stimuli including both infectious and noninfectious causes.
The definition of SIRS is based on physiological parameters
including body temperature, heart rate, respiration rate (of
oxygen saturation), and abnormal leukocytes counts
(leukocytosis, an elevation of immature neutrophils or
leukopenia). GI dysfunction is common in critically ill pa-
tients. Fifty-nine percent of critically ill patients have at
least one GI symptom during their stay in ICUs.26 However,
evaluating the small bowel is difficult; it is a deep organ,
and critically ill patients are frequently unable to inform
clinicians about digestive complaints. Therefore, small
bowel dysfunction may sometimes be occult or mis-
diagnosed. The role of gut injury and inflammation in major
trauma-induced SIRS and multiple organ dysfunction
syndrome have been known for decades without clearclinical evidence. The gut origin hypothesis suggests that
gut barrier function failure due to a major stress insult
permits bacterial and endotoxin translocation, which
triggers splanchnic cytokines to perpetuate and exacerbate
a systemic immunoinflammatory response that may result
in organ failure.27 However, gut barrier dysfunction could
not be directly linked to sepsis.27 Our data indicate that
enterocyte damage upon admission to the ER is common in
patients with SIRS and increased enterocyte damage
related to their SOFA scores. In summary, our data suggest
that serum IFABP may be a reliable indicator of multiple
organ failure in patients with SIRS, and that increased
enterocyte damage indicates multiple organ failure. From
this viewpoint, increased IFABP may indicate intestinal
barrier failure and subsequent bacterial translocation in
critically ill patients. Using therapeutic strategies such as
early enteral feeding or vasopressor agents to decrease
enterocyte damage could be useful in preventing multiple
organ failure in critically ill patients.
The pathophysiology of enterocyte damage in critically
ill patients may be mediated by nonocclusive mesenteric
ischemia. Acute mesenteric ischemia is defined as a recent
and rapid imbalance between the demand and the delivery
of oxygen and nutrients to the splanchnic area.28 We found
that low systolic BP, a cause of nonocclusive mesenteric
ischemia, was associated with high IFABP concentrations in
the investigated patients. These results were further
corroborated by the negative correlation between diastolic
BP and IFABP concentration. Moreover, the results of the
multivariate analysis indicate that mean BP correlates
negatively with IFABP concentration. In summary, our data
suggest that low BP in patients with SIRS may induce
enterocyte damage through mesenteric ischemia. More-
over, serum IFABP concentrations are significantly elevated
in patients with systolic BP below 90 mmHg, suggesting that
maintaining the systolic BP above 90 mmHg is crucial for
preventing enterocyte damage and subsequent organ fail-
ure in critically ill patients.
A recent study found that patients with chronic
obstructive pulmonary disease (COPD) have altered intes-
tinal permeability at rest. Furthermore, performing activ-
ities of daily living significantly increased plasma IFABP
concentrations in patients with COPD but not in a group of
controls. These findings indicate that patients with COPD
are prone to have altered GI tract function.29 However, the
correlation between respiratory function and intestinal
barrier failure in critically ill patients has not been char-
acterized. Deitch19 reported that the systemic spread of
gut-derived factors leading to lung injury and systemic
inflammation occurs through the intestinal lymphatics. Our
data further suggest that tachypnea is associated with
enterocyte damage. Because the respiratory rate was
checked upon admission to the ER after the enterocyte
damage had already occurred, we speculate that tachyp-
nea is a result, rather than a cause, of enterocyte damage
in patients with SIRS.
Gut-derived endotoxin is a contributing factor for the
development of low-grade inflammation, which is a hallmark
for type 2 diabetes development.30 Diabetes mellitus is a
chronic, progressive, medically incurable disease, and is
predominantly an intestinal disease. Increased intestinal
Enteric bacterial loads correlate with IL-6 levels 215permeability, altered intestinal microbiota, and subsequent
metabolic endotoxemia have been suggested to be causal
factors in type 2 diabetes.31 However, patients with type 2
diabetes do not shown higher intestinal permeability
compared with healthy controls.32 Hyperglycemia and insu-
lin resistance are virtually universal in sepsis. Hyperglycemia
is potentially harmful because it acts as a procoagulant,33
induces apoptosis,34 impairs neutrophil function, impairs
wound healing, and is associated with an increased risk of
death. However, the appropriate target glucose ranges in
patients with sepsis are unknown. Furthermore, insulin
therapy in ICU patients does not cause a significant differ-
ence in mortality.35 Our data suggest that hyperglycemia is
associated with enterocyte damage in patients with SIRS.
Increased enterocyte damage may cause increased intestinal
permeability and subsequent metabolic endotoxemia in pa-
tients with hyperglycemia. Moreover, our data suggest that
enterocyte damage is significantly higher in patients with
blood sugar levels of 230 mg/dL. In the future, maintaining
blood sugar at <230 mg/dL may assist in preventing an in-
crease in intestinal permeability and subsequent metabolic
endotoxemia in patients with SIRS.
In summary, enterocyte injury is a crucial factor
contributing to excessive inflammation. Gut barrier func-
tion failure may permit enteric bacteria to enter the blood,
thereby triggering an increase in systemic IL-6 levels.
Hypotension may be a major factor for enterocyte damage
in patients with SIRS admitted to the ER. Respiration rate
correlates positively with enterocyte damage. Maintaining
blood sugar levels at <230 mg/dL may help prevent
enterocyte damage in patients with SIRS. C-reactive
protein concentrations correlate positively with sCD14
levels. Using therapeutic strategies to alleviate hypoten-
sion and tachypnea may further prevent intestinal
complications, bacterial translocation, and subsequent
multiple organ failure in patients with severe trauma.References
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